NASDAQ · TLNCU
Financial Services · Asset Management
$10.35
Down-$0.07 (-0.67%)
Updated Nov 8, 2026, 7:33 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · TLNCU
1M range · 5 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
TLNCU closed at $10.35 after 5 trading sessions, down 0.67% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $10.36 | $10.36 | $10.35 | $10.35 | 600 |
| Nov 2, 2026 | $10.4009 | $10.4351 | $10.35 | $10.42 | 5.9K |
| Oct 30, 2026 | $10.43 | $10.439 | $10.40 | $10.439 | 2.12K |
| Oct 15, 2026 | $10.42 | $10.42 | $10.42 | $10.42 | 100 |
| Oct 14, 2026 | $10.42 | $10.42 | $10.42 | $10.42 | 300 |
The latest Smart Investors Daily articles mentioning TLNCU.
Company
Market Activity
Research & News
TLNCU research
Company profile and research snapshot.
Talon Capital Corp is a newly organized blank check company.
Consensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Jan 13, 2026
Oricell Therapeutics Holdings Limited ("Oricell" or "the Company"), a global leader in innovative cancer immunotherapy, announced today the closing of a $70M Series C1 financing.
globenewswire.com · Oct 3, 2025
Houston, TX, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Talon Capital Corp. (the “Company”) announced today that, commencing on or about Wednesday, October 8, 2025, holders of the units sold in the Company's initial public offering may elect to separately trade the Class A ordinary shares and warrants included in the units.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning TLNCU.
No results
No recent SID articles mention TLNCU.
